Icotinib, an effective treatment option for patients with lung adenocarcinoma harboring compound EGFR L858R and A871G mutation

Jin, LL; Wu, ZZ; Wang, YL; Chen, DS; Li, S; Xiao, MZ; Zhao, X

Zhao, X (corresponding author), Nanjing Med Univ, Jiangsu Prov Hosp, Dept Resp & Crit Care Med, Nanjing 210002, Peoples R China.; Zhao, X (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Nanjing 210002, Peoples R China.

INVESTIGATIONAL NEW DRUGS, 2021; 39 (5): 1419